Liposome-encapsulated panomycocin: preparation, characterization and in-vitro determination of antifungal efficacy against vulvovaginal candidiasis

Date

2016

Author

Bayram, Günce

Metadata

Show full item record

Item Usage Stats

133
views

0
downloads

Vulvovaginal candidiasis is a serious yeast infection that affects 80% of all women worldwide. In this study, a liposomal lyophilized powder formulation of Panomycocin was developed for therapeutic purposes against vulvovaginal candidiasis. Panomycocin is a potent antimycotic/antifungal protein secreted by Pichia anomala NCYC 434 strain previously shown to be fungicidal against Candida species which are the causal agents of vulvovaginal candidiasis. This study consists of the preparation of stratum corneum liposomes with a lipid composition identical to that of the vaginal epithelium, loading of the liposomes with Panomycocin, characterization of the liposomes and determination of biological activity of Panomycocin loaded liposomes on an in vitro human vaginal epithelium tissue model. In TEM analyses the liposomes showed size in the nano scale and regular morphology. The encapsulation and loading efficiencies of liposome nanoparticles were found as 73% and 76.8% respectively. Zeta potential measurements revealed uniform charge distribution on nanoparticle surfaces and stable nanoparticles. FTIR analyses revealed the lack of covalent interactions between encapsulated Panomycocin and liposome nanoparticles. DLS analyses showed that the nanoparticles have uniform size distribution. XRD analyses showed that they were amorphous. The liposomes released 1.71% of encapsulated Panomycocin in aqueous solution. All encapsulated Panomycocin was released when the liposomal lyophilized powder formulation was applied on in vitro human vaginal epithelium tissue model contaminated with Candida species; yielding MFC values comparable to that of pure Panomycocin. This liposomal lyophilized powder formulation of Panomycocin prepared specially with stratum corneum lipids may be subjected to further preclinical and clinical trials to develop an effective antimycotic/antifungal drug for the treatment of vulvovaginal candidiasis.

Subject Keywords

Panomycocin., Pichia anomala., Antifungal agents., Candidiasis, Vulvovaginal.

URI

http://etd.lib.metu.edu.tr/upload/12620379/index.pdf
https://hdl.handle.net/11511/25988

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

Liposome-encapsulated panomycocin: preparation, characterization and in vitro determination of antifungal efficacy against dermatophytes Tosun, Kübra; İzgü, Kadri Fatih; Özkan, Yalçın; Department of Biotechnology (2016) Dermatopytosis is one of the most seen superficial fungal infections in humans resulting mild to severe inflammations. Antifungal drugs are not effective in the treatment of dermatophytosis due to serious adverse effects and resistance developed by fungal pathogens. Thus, the development of safe, naturally derived and potent antifungal/antimycotic agents which do not result in resistance and elicit little or no side effects to mammalian cells with high selectivity to the fungal pathogens is a continuing nee...
VanA-Type MRSA (VRSA) Emerged in Surface Waters İçgen, Bülent (Springer Science and Business Media LLC, 2016-09-01) Due to the widespread occurrence of mecA-encoded methicillin resistance in Staphylococcus aureus (MRSA), treatment of staphylococcal infections is shifted to glycopeptide antibiotics like vancomycin and teicoplanin. The selective pressure of glycopeptides has eventually led to the emergence of staphylococci with increased resistance. Of great concern is vanA-encoded high level vancomycin and teicoplanin resistance in MRSA (VRSA). Therefore, this study aimed at investigating the occurrence of VRSA in surface...
Stratum corneum lipid liposome-encapsulated panomycocin: preparation, characterization, and the determination of antimycotic efficacy against Candida spp. isolated from patients with vulvovaginitis in an in vitro human vaginal epithelium tissue model İzgü, Kadri Fatih; Tosun, Kubra; Izgu, Demet (2017-01-01) In this study, a liposomal lyophilized powder formulation of panomycocin was developed for therapeutic purposes against vulvovaginal candidiasis which affects 80% of women worldwide. Panomycocin is a potent antimycotic protein secreted by the yeast Wickerhamomyces anomalus NCYC 434. This study involved the preparation of panomycocin-loaded stratum corneum lipid liposomes (SCLLs), characterization of the SCLLs, and determination of antimycotic efficacy of the formulation against Candida albicans and Candida ...
Health-related quality of life of women with endometriosis: An Attachment-Diathesis Model of Chronic Pain perspective Güvenç, İrem Berna; Bozo Özen, Özlem (2023-01-01) Endometriosis is a common gynecological disorder that occurs in women of reproductive age, and negatively affects women’s quality of life. We tested ‘Attachment-Diathesis Model of Chronic Pain’ in a sample of Turkish women with endometriosis by analyzing the paths among attachment styles, pain catastrophizing, coping strategies, and health-related quality of life (HRQoL). Attachment anxiety was related to using less problem-focused coping and seeking more social support, while attachment avoidance was assoc...
Thermostabilization of panomycocin, a novel exo-beta-1,3-glucanase isolated from pichia anomala NCYC 434, by using excipients and computational methods Muhammed, Muhammed Tilahun; İzgü, Kadri Fatih; Son, Çağdaş Devrim; Department of Biomedical Engineering (2015) As the risks for fungal infections increased, the prevalence of invasive fungal infections increased. Therefore, the demand for antifungal agents has risen. Moreover, the currently used antifungal agents have serious side effects and resistance development resulting from their mechanisms of action. Thus, novel antifungal agents with mechanisms that will not affect the host mammalian cells are in need. Yeast killer proteins which are naturally occuring toxins are good candidates for such types of agents. Pan...

Citation Formats

G. Bayram, “Liposome-encapsulated panomycocin: preparation, characterization and in-vitro determination of antifungal efficacy against vulvovaginal candidiasis,” M.S. - Master of Science, Middle East Technical University, 2016.